quinidine has been researched along with ly335979 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Baughman, TM; Bell, MG; Cao, J; Dantzig, AH; Ehlhardt, WJ; Elmquist, WF; Gruber, J; Kroin, JS; Law, KL; Norman, BH; Shepard, RL; Shih, C; Starling, JJ; Winter, MA | 1 |
Bungay, PM; Elmquist, WF; Sun, H | 1 |
Fang, Z; Harder, A; Laplanche, L; Mezler, M; Weinheimer, M; Ye, D | 1 |
3 other study(ies) available for quinidine and ly335979
Article | Year |
---|---|
Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.
Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dibenzocycloheptenes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Isoquinolines; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Quinidine; Quinolines; Structure-Activity Relationship; Tetrahydroisoquinolines; Tumor Cells, Cultured; Verapamil | 1997 |
Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain.
Topics: Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Capillary Permeability; Carrier Proteins; Cross-Over Studies; Dibenzocycloheptenes; Fluoresceins; Fluorescent Dyes; Frontal Lobe; Male; Microdialysis; Models, Biological; Probenecid; Quinidine; Quinolines; Rats; Rats, Wistar; Sensitivity and Specificity; Time Factors | 2001 |
Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Brain; Caco-2 Cells; Cell Membrane Permeability; Dibenzocycloheptenes; Diketopiperazines; Dogs; Drug Evaluation, Preclinical; Heterocyclic Compounds, 4 or More Rings; Humans; Madin Darby Canine Kidney Cells; Neoplasm Proteins; Pharmacokinetics; Prazosin; Quinidine; Quinolines; Substrate Specificity; Transfection | 2020 |